Document



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K
_______________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 9, 2018
_______________
CYRUSONE INC.
(Exact Name of Registrant as Specified in its Charter)
_______________
Maryland
 
001-35789
 
46-0691837
(State of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
2101 Cedar Springs Road, Suite 900
Dallas, TX 75201
(Address of Principal Executive Office)
Registrant’s telephone number, including area code: (972) 350-0060
_______________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




Item 5.07 — Submission of Matters to a Vote of Security Holders.
On May 9, 2018, CyrusOne Inc. (the “Company”) held its 2018 Annual Meeting of Stockholders (the “Annual Meeting”). The final voting results are set forth below.
Proposal 1: The stockholders elected each of the eight director nominees to the Board of Directors of the Company to serve until the 2019 Annual Meeting of Stockholders, as follows:
 
 
 
 
Votes
 
Broker
 
 
Votes For
 
Withheld
 
Non-Votes
David H. Ferdman
 
83,535,897

 
508,975

 
5,748,883

John W. Gamble, Jr.
 
83,110,971

 
933,902

 
5,748,883

Michael A. Klayko
 
81,406,790

 
2,638,083

 
5,748,883

T. Tod Nielsen
 
80,520,477

 
3,524,396

 
5,748,883

Alex Shumate
 
81,863,781

 
2,181,091

 
5,748,883

William E. Sullivan
 
81,841,902

 
2,202,971

 
5,748,883

Lynn A. Wentworth
 
82,081,678

 
1,963,195

 
5,748,883

Gary J. Wojtaszek
 
83,535,521

 
509,352

 
5,748,883

Proposal 2: The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as follows:
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
71,728,425
 
11,521,775
 
794,672
 
5,748,883
Proposal 3: The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2018, as follows:
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
89,671,856
 
58,024
 
63,876
 
0

2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
CYRUSONE INC.
 
 
 
Date: May 14, 2018
By:
/s/ Robert M. Jackson
 
 
Robert M. Jackson
 
 
Executive Vice President, General Counsel and Secretary


3